检索结果 - Werner Engl

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies

    Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies 由 Rolf Gustafson, Ann Gardulf, Susanne V. Hansen, Heinz Leibl, Werner Engl, Magdalena Lindén, Anne Müller, Lennart Hammarström

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Extended half‐life pegylated, full‐length recombinant factor <scp>VIII</scp> for prophylaxis in children with severe haemophilia A

    Extended half‐life pegylated, full‐length recombinant factor <scp>VIII</scp> for prophylaxis in children with severe haemophilia A 由 Eric S. Mullins, Oleksandra Stasyshyn, María Román, David Osman, Ri Liesner, Werner Engl, Marlies Sharkhawy, Brigitt E. Abbuehl

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study

    Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study 由 Robert Klamroth, Jerzy Windyga, Vlad C. Radulescu, Peter W. Collins, Oleksandra Stasyshyn, Hishamshah Mohd Ibrahim, Werner Engl, Srilatha Tangada, William Savage, Bruce M. Ewenstein

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies

    Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies 由 Michael Borte, G. Kriván, Beáta Dérfalvi, László Maródi, Thomas Harrer, Stephen Jolles, Christelle Bourgeois, Werner Engl, Heinz Leibl, Barbara McCoy, David Gelmont, Leman Yel

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency

    Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency 由 Richard L. Wasserman, Isaac Melamed, Mark R. Stein, Sudhir Gupta, Jennifer M. Puck, Werner Engl, Heinz Leibl, Barbara McCoy, Victoria Empson, David Gelmont, Richard I. Schiff

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

    Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A 由 Barbara A. Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone, Bruce M. Ewenstein, Brigitt E. Abbuehl

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency

    Long-Term Tolerability, Safety, and Efficacy of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulin for Primary Immunodeficiency 由 Richard L. Wasserman, Isaac Melamed, Mark R. Stein, Werner Engl, Marlies Sharkhawy, Heinz Leibl, Jennifer M. Puck, Arye Rubinstein, Lisa Kobrynski, Sudhir Gupta, Andrew J. Grant, Anoshie Ratnayake, Wendell Richmond, Joseph A. Church, Leman Yel, David Gelmont

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

    Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial 由 Pier Mannuccio Mannucci, Christine L. Kempton, Carolyn M. Millar, Edward H. Romond, Amy D. Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, T. T. Yee, Robert Klamroth, Wing-Yen Wong, Miranda Chapman, Werner Engl, Peter L. Turecek, Tobias M. Suiter, Bruce M. Ewenstein

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: